In contrast to FOXM1 knockdown, following drug treatment we observed reduced cell growth due to apoptosis in both AML cells and in normal CD34+ HSPCs at similar IC50s (Figs. S6A-D). This evidence concerns the gene FOXM1 and acute myeloid leukemia.